INO Stock News: Inovio Pharmaceuticals Inc. gyrates around the previous close above $23.00
|- Inovio Pharmaceuticals Inc. (NASDAQ: INO) partially fades Tuesday’s advance.
- NASDAQ: INO faces the next resistance at $25.00.
Shares of Inovio Pharmaceuticals Inc. (NASDAQ: INO) are trading without a clear direction during the premarket activity and ahead of key weekly data from the US labour market on Thursday.
After clinching fresh monthly tops around the $25.00 yardstick on Tuesday, Inovio Pharmaceuticals Inc. (NASDAQ: INO) has given away part those gains and is now hovering below $24.00
There are no changes to the scenario around the biotech pharma company, which plans to start the Phase 2/3 of its study for a COVID-19 vaccine (INO-4800) this summer (pending FDA approval).
In the meantime, US benchmark stock indices remain mixed ahead of the opening bell in Wall St., with both the NASDAQ and S&P500 posting modest gains in contrast to the marginal losses seen in the DowJones. As usual, investors continue to gauge the potential economic recovery vs. the impact of the second wave of the coronavirus pandemic.
INO Stock Quote
As of writing NASDAQ: INO is losing 0.55% at $23.33 and faces the next support at $16.92 (monthly high May 20) seconded by $15.44 (55-day SMA) and finally $11.13 (monthly high Jun.8). On the upside, a surpass of $24.99 (weekly high Jul.7) would expose $33.79 (monthly high Jun.23) and then $40.00 (high September 2000).
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.